会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 84. 发明公开
    • MICROPROJECTION ARRAY HAVING A BENEFICIAL AGENT CONTAINING COATING AND METHOD OF FORMING THE COATING THEREON
    • 具有含涂层的有益剂的微喷射阵列和形成涂层的方法
    • EP3251722A1
    • 2017-12-06
    • EP17175113.4
    • 2002-04-20
    • ALZA Corporation
    • Cormier, Michael JDaddona, Peter EJohnson, Juanita AYoung, Wendy A
    • A61M37/00
    • A61M37/0015A61B17/205A61K9/0014A61K9/0021A61K47/42A61M2037/0007A61M2037/0023A61M2037/0053
    • A method of forming a solid coating on microprojections in a microprojection array, comprising the steps of: (a) applying a liquid composition comprising one or more beneficial agents, a biocompatible carrier and a volatile liquid to the microprojections; (b) drying said liquid composition on said microprojections; (c) optionally, repeating steps (a) and (b) one or more times, to form said solid coating on said microprojections in the microprojection array, wherein the solid coating is adapted to allow release of the one or more beneficial agents from the coating upon hydration of the coating, and wherein said liquid composition has a beneficial agent concentration of from 1% to 30% by weight, and wherein the weight ratio of all biocompatible carriers to all beneficial agents ranges from 0.2:1 to 5:1. Also provided is a device for delivering a beneficial agent through the stratum corneum, comprising a plurality of microprojections and a solid coating obtainable by the method of the invention disposed upon at least a portion of the microprojections.
    • 包括以下步骤:(a)将包含一种或多种有益物质,生物相容性载体和挥发性液体的液体组合物施加到微喷射体上;(b)在微喷射体阵列中形成固体涂层, (b)干燥所述微喷射体上的所述液体组合物; (c)任选地,重复步骤(a)和(b)一次或多次以在所述微突出物阵列中的所述微突物上形成所述固体涂层,其中所述固体涂层适于允许所述一种或多种有益试剂从 并且其中所述液体组合物具有1重量%至30重量%的有益剂浓度,并且其中所有生物相容性载体与所有有益剂的重量比在0.2:1至5:1的范围内。 还提供了用于通过角质层递送有益剂的装置,其包含多个微突出物和通过设置在至少一部分微突出物上的本发明方法可获得的固体涂层。
    • 89. 发明公开
    • METHODS AND SYSTEMS FOR MODULATING MEDICANTS USING ACOUSTIC ENERGY
    • 方法和系统调制药物的使用声能
    • EP3181183A1
    • 2017-06-21
    • EP16189694.9
    • 2008-05-07
    • Guided Therapy Systems, L.L.C.
    • MAKIN, Inder Raj S.SLAYTON, Michael HBARTHE, Peter G
    • A61M37/00A61B8/00A61N7/00A61N7/02A61B90/00
    • A61M37/0092A61B8/4281A61B2090/378A61M2037/0007A61M2205/3375A61N7/00A61N7/02A61N2007/0008A61N2007/0043A61N2007/0056
    • This invention provides methods and systems uniquely capable of enhancing medicant delivery and/or effectiveness through the use of energy to predictably disrupt membranes and mechanically and thermally modulate cells and tissues. In exemplary embodiments, the methods and systems disclosed herein are capable of modulating multiple layers of tissue. In an exemplary embodiment, the energy is acoustic energy (e.g., ultrasound). In other exemplary embodiments, the energy is photon based energy (e.g., IPL, LED, laser, white light, etc.), or other energy forms, such radio frequency electric currents, or various combinations of acoustic energy, electromagnetic energy and other energy forms or energy absorbers such as cooling. Medicants can be first introduced to the region of interest by diffusion, circulation, and/or injection. An exemplary system (14) for enhancing medicant delivery and/or effectiveness comprises a control system (20), a probe (18), and a display (22) or indicator (22) system. Imaging and/or monitoring may alternatively be coupled and/or co-housed with an ultrasound system contemplated by the present invention.
    • 本发明提供的方法和系统能够提高Medicant递送和/或有效性通过使用能量的可预测破坏膜和机械和热调节细胞和组织的唯一。 在示例性的实施方案中,方法和系统盘在游离缺失能够调节组织的多层组成。 在一个示例性实施例中,能量是声能(E. G.,超声)。 在其它示例性实施例中,该能量是基于光子能量(例如,IPL,LED,激光,白光,等),或其它能量形式,求射频电流,或声能,电磁能和其他能源的各种组合 形式或能量吸收器:如冷却。 Medicants可以首次引入的通过扩散,循环,和/或注射感兴趣的区域。 示例性的系统(14)用于增强Medicant递送和/或有效性的样品包括一个控制系统(20),(18),和显示器(22)或指示器(22)系统。成像和/或监测可以可选地耦合 和/或共容纳在与由本发明设想的超声系统。